RPL32P26

Across TCGA pan-cancer cohorts, RPL32P26 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPL32P26’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL32P26 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL32P26 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

COAD, LUAD, and PRAD are the cancer types where RPL32P26 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P26 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.243	.002	5	view →
LUAD	All	All	+0.233	<.001	3	view →
PRAD	All	All	+0.202	.002	2	view →
LIHC	All	II,III,IV	+0.070	.010	2	view →
HNSC	Male	All	+0.064	.020	2	view →
THCA	Female	All	−0.107	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPL32P26–COAD

Open the COAD breakdown →